Nearly 600K inhalers for improper dosage delivery

(WTEN) – GlaxoSmithKline is recalling more than 590,000 albuterol inhalers.

The affected lot numbers are 6ZP0003, 6ZP9944 and 6ZP9848. The inhalers have been recalled from hospitals, pharmacies, retailers and wholesalers.

When functioning properly, the devices release a fixed dose of the medication albuterol to treat conditions like asthma. The British pharmaceutical company said the recalled devices could potentially deliver incorrect dosages.

The voluntary recall is not on the patient level, but patients are encouraged to seek immediate medical attention if their inhaler is not relieving symptoms.

If a patient’s inhalers are among the affected lots, contact GSK customer service center at 1-888-825-5249. provides commenting to allow for constructive discussion on the stories we cover. In order to comment here, you acknowledge you have read and agreed to our Terms of Service. Commenters who violate these terms, including use of vulgar language or racial slurs, will be banned. Please be respectful of the opinions of others and keep the conversation on topic and civil. If you see an inappropriate comment, please flag it for our moderators to review.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s